Literature DB >> 15569908

Prevalence of chronic obstructive pulmonary disease among those with serious mental illness.

Seth Himelhoch1, Anthony Lehman, Julie Kreyenbuhl, Gail Daumit, Clayton Brown, Lisa Dixon.   

Abstract

OBJECTIVE: Individuals with serious mental illness have elevated smoking rates, and smoking is a significant risk factor for chronic obstructive pulmonary disease (COPD). The goal was to determine the prevalence of COPD among those with serious mental illness.
METHOD: The authors surveyed a random sample of 200 adults with serious mental illness with questions from the National Health and Nutrition Examination Study III that were previously used to estimate the national prevalence of COPD. They compared the prevalence of COPD in the sample to a randomly selected matched subset of national comparison subjects.
RESULTS: The prevalence of COPD was 22.6%. Those with serious mental illness were significantly more likely to have chronic bronchitis (19.5% versus 6.1%) and emphysema (7.9% versus 1.5%) than the comparison subjects.
CONCLUSIONS: The prevalence of COPD is significantly higher among those with serious mental illness than comparison subjects. Improved primary and secondary prevention is warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15569908     DOI: 10.1176/appi.ajp.161.12.2317

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  37 in total

1.  Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems.

Authors:  Alisa B Busch; Arnold M Epstein; Thomas G McGuire; Sharon-Lise T Normand; Richard G Frank
Journal:  J Ment Health Policy Econ       Date:  2015-09

2.  Teaching medical students about communicating with patients with major mental illness.

Authors:  Lisa I Iezzoni; Radhika A Ramanan; Stacey Lee
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

3.  Serious mental illness and acute hospital readmission in diabetic patients.

Authors:  Jennifer S Albrecht; Jon Mark Hirshon; Richard Goldberg; Patricia Langenberg; Hannah R Day; Daniel J Morgan; Angela C Comer; Anthony D Harris; Jon P Furuno
Journal:  Am J Med Qual       Date:  2012-04-26       Impact factor: 1.852

4.  Physical wellness and employment status among adults with serious mental illness.

Authors:  Richard W Goldberg; Ann Hackman; Deborah R Medoff; Clayton Brown; Li Juan Fang; Faith Dickerson; Julie Kreyenbuhl; Lisa Dixon
Journal:  Community Ment Health J       Date:  2008-03-18

5.  Investigation into the cause of death of a 56-year-old man with serious mental illness.

Authors:  Judith J Prochaska; Rebecca Schane; Desiree Leek; Stephen E Hall; Sharon M Hall
Journal:  Am J Psychiatry       Date:  2008-04       Impact factor: 18.112

6.  Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes.

Authors:  Anne C Melzer; Laura C Feemster; Margaret P Collins; David H Au
Journal:  J Gen Intern Med       Date:  2016-02-22       Impact factor: 5.128

7.  High rates of obstructive sleep apnea symptoms among patients with schizophrenia.

Authors:  Aniyizhai Annamalai; Laura B Palmese; Lydia A Chwastiak; Vinod H Srihari; Cenk Tek
Journal:  Psychosomatics       Date:  2014-03-02       Impact factor: 2.386

Review 8.  Tobacco use among individuals with schizophrenia: what role has the tobacco industry played?

Authors:  Judith J Prochaska; Sharon M Hall; Lisa A Bero
Journal:  Schizophr Bull       Date:  2007-11-05       Impact factor: 9.306

Review 9.  Tobacco use treatment in primary care patients with psychiatric illness.

Authors:  Joseph M Cerimele; Abigail C Halperin; Andrew J Saxon
Journal:  J Am Board Fam Med       Date:  2014 May-Jun       Impact factor: 2.657

10.  Health behavior risk factors across age as predictors of cardiovascular disease diagnosis.

Authors:  Michelle Cardi; Niki Munk; Faika Zanjani; Tina Kruger; K Warner Schaie; Sherry L Willis
Journal:  J Aging Health       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.